Researchers track Real-World side effects in lung cancer patients
NCT ID NCT07215962
Summary
This study looks back at medical records to understand the side effects and healthcare needs of 300 people with advanced lung cancer who have low levels of a specific protein (PD-L1). It examines patients who received various first-line immunotherapy treatments to see how common side effects were, when they occurred, and what healthcare resources were needed to manage them. The goal is to gather real-world information to help doctors better understand treatment safety.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER (NSCLC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Florida Cancer Specialists & Research Institute
Fleming Island, Florida, 32003, United States
Conditions
Explore the condition pages connected to this study.